Global Hemostasis/Coagulation Analyzers Market Size & Share, Application Analysis, Growth Trends, Key Players and Competitive Strategies - Forecast to 2026
DUBLIN, Sept. 18, 2018 /PRNewswire/ --
The "Global Hemostasis/Coagulation Analyzers Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2018 To 2026" report has been added to ResearchAndMarkets.com's offering.
The global hemostasis/coagulation analyzers market was valued at US$ 3,650.1 Mn in 2017 and expected to reach US$ 9,548 Mn by 2026, expanding at a CAGR of 9.9% from 2018 to 2026.
Growing incidence of blood disorders is mainly attributed to the growth of hemostasis analyzers market. Perpetual innovation in technology and miniaturization has led to commercialization of many novel devices that have quick turnaround time and also can be used in point of care settings. Furthermore, growing awareness and demand for technologically advanced medical treatments, support from governments and growing adoption of laboratory automation urges the demand for novel coagulation analyzers.
The global hemostasis/coagulation analyzers market is segmented based on test types, product types, and end users. Among the test types, routine coagulation tests occupy the largest share of the global market. A large number of these tests being performed for almost all surgical procedures and treatments mainly assists in the dominance of this segment. Growing adoption of specific tests such as VWF assays and thrombophilia testing in the light of growing awareness and prevalence of coagulation disorders will facilitate faster growth rate to diagnostic hemostasis assays segment. Currently, between devices (analyzers) and consumables, the former segment holds larger revenue share globally. Higher cost and consistently growing purchase of these systems both in laboratory and point of care settings are attributed to the prominence of devices segment.
Based on end users, the global hemostasis/coagulation analyzers market is studied for hospitals & clinics, diagnostic laboratories, and research institutions. Among these, the diagnostic laboratories segment dominated the global market. Greater preference of analyzing samples in specialized laboratories mainly drives this segment. The uptake of hemostasis analyzers is high in research institutions due to the surge in the number of clinical trials being undertaken for treatment development and innovating diagnostic solutions.
In 2017, North America dominated the global hemostasis analyzers market in terms of revenue, due to the existence of developed healthcare infrastructure, a multitude of R&D initiatives, a high number of organ transplant and general surgeries being performed in the region and so on. On the other hand, Asia Pacific region will witness the fastest growth on the global front. Growing awareness about hemostasis, increasing disease prevalence both genetic and lifestyle linked and increasing healthcare expenditure are the major drivers of this regional market.
The competitive front of the hemostasis industry is intense and is characterized by the presence of several multinational players. The major market players have intensified their R&D efforts towards the development of technologically advanced and more accurate analyzers. They are also undertaking penetration measures to enter the untapped markets of the Asia Pacific and Middle East & Africa.
Key Highlights
- Growing incidence of hematological diseases and increasing preference for coagulation tests in all surgical procedures
- The rapid evolution of healthcare infrastructure in untapped markets of Asia Pacific
- Growing preference for novel compact and automatic analyzers that can be used in point of care settings
- Growing efforts to commercialize novel drugs for the treatment of coagulation disorders
- Rapid penetration of major market players in the emerging regions and Asia Pacific, parts of Latin America and Middle East & Africa
Key Topics Covered
Chapter 1. Preface
1.1. Report Description
1.2. Market Segmentation
1.3. Research Scope
1.4. Research Methodology
1.5. Market Segmentation
Chapter 2. Executive Summary
2.1. Global Hemostasis/Coagulation Analyzers Market Portraiture
2.2. Global Hemostasis/Coagulation Analyzers Market, by Test, 2017 (US$ Mn)
2.3. Global Hemostasis/Coagulation Analyzers Market, by Product, 2017 (US$ Mn)
2.4. Global Hemostasis/Coagulation Analyzers Market, by End User, 2017 (US$ Mn)
2.5. Global Hemostasis/Coagulation Analyzers Market, by Geography, 2017 (US$ Mn)
Chapter 3. Global Hemostasis/Coagulation Analyzers Market: Dynamics and Future Outlook
3.1. Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global Hemostasis/Coagulation Analyzers Market, by Key Players, 2017
Chapter 4. Global Hemostasis/Coagulation Analyzers Market, by Test, 2016-2026 (US$ Mn)
4.1. Overview
4.2. Routine Coagulation Tests
4.3. Diagnostic Hemostasis Assays
Chapter 5. Global Hemostasis/Coagulation Analyzers Market, by Product, 2016-2026 (US$ Mn)
5.1. Overview
5.2. Consumables
5.3. Devices
Chapter 6. Global Hemostasis/Coagulation Analyzers Market, by End User, 2016-2026 (US$ Mn)
6.1. Overview
6.2. Hospitals & Clinics
6.3. Diagnostic Laboratories
6.4. Clinical laboratories & Research Institutions
Chapter 7. Global Hemostasis/Coagulation Analyzers Market, by Geography, 2016-2026 (US$ Mn)
7.1. Overview
7.2. Europe Hemostasis/Coagulation Analyzers Market, 2016-2026 (US$ Mn)
7.3. Asia Pacific Hemostasis/Coagulation Analyzers Market, 2016-2026 (US$ Mn)
7.4. Latin America Hemostasis/Coagulation Analyzers Market, 2016-2026 (US$ Mn)
7.5. Middle East & Africa Hemostasis/Coagulation Analyzers Market, 2016-2026 (US$ Mn)
Chapter 8. Company Profiles
8.1. Alere Inc. (Abbott Laboratories, Inc.)
8.2. F-Hoffmann La Roche
8.3. Sysmex Corporation
8.4. Beckman Coulter, Inc. (Danaher)
8.5. Nihon Kohden Corporation
8.6. Thermo Fisher Scientific Inc.
8.7. Siemens Healthcare (Siemens AG)
8.8. International Technidyne Corporation (Werfen)
8.9. Beckman Coulter Inc.
For more information about this report visit https://www.researchandmarkets.com/research/g579zd/global?w=5
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Share this article